MET and metastatic malignant neoplasm in the lymph nodes: However, c-MET expression was not associated with lymph node metastasis (OR = 1.21, 95% CI: 0.89–1.64; p = 0.23; Figure 4), tumour differentiation (OR = 1.30, 95% CI: 0.94–1.81; p = 0.12; Figure 4), sex (OR = 1.04, 95% CI: 0.73–1.48; p = 0.21; Figure 4) or T classification (OR = 1.88, 95% CI: 0.87–4.08; p = 0.11; Figure 4).